PubRank

J Behrens

Author PubWeight™ 89.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991 8.60
2 Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994 5.81
3 E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton. J Cell Biol 1994 4.34
4 Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990 4.05
5 Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin. J Cell Biol 1985 3.77
6 The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003 3.06
7 Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 1996 3.00
8 E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991 2.67
9 Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A 1987 2.50
10 Biochemical interactions in the wnt pathway. Biochim Biophys Acta 2000 1.96
11 V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and beta catenin is not required for the shift. J Cell Biol 1995 1.92
12 Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008 1.76
13 Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol 2000 1.67
14 Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer 1991 1.61
15 Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 1995 1.61
16 Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001 1.60
17 Monoacetoxyscirpenol. A new mycotoxin produced by Fusarium roseum Gibbosum. J Agric Food Chem 1976 1.55
18 Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J Biol Chem 2000 1.50
19 Tumor-suppressor gene products in cell contacts: the cadherin-APC-armadillo connection. Curr Opin Cell Biol 1994 1.48
20 Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 1993 1.41
21 RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol Cell Biol 1998 1.39
22 Iron in prenatal multivitamin/multimineral supplements. Bioavailability. J Reprod Med 1998 1.38
23 Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000 1.34
24 Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J Cell Sci Suppl 1993 1.34
25 Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 1996 1.29
26 Nutritional interventions for preventing and treating pressure ulcers. Cochrane Database Syst Rev 2003 1.26
27 Uterotropic activity of cis and trans isomers of zearalenone and zearalenol. Appl Environ Microbiol 1978 1.13
28 Expression of E-cadherin and catenins in invasive mammary carcinomas. Anticancer Res 1997 1.10
29 Effort-reward imbalance and burnout among German nurses in medical compared with psychiatric hospital settings. J Psychiatr Ment Health Nurs 2009 1.10
30 Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 1999 1.07
31 Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol 2003 1.05
32 Substances interfering with the gas-liquid chromatographic determination of T-2 mycotoxin. J Assoc Off Anal Chem 1976 1.05
33 Epithelial differentiation and the control of metastasis in carcinomas. Curr Top Microbiol Immunol 1996 1.01
34 Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994 1.01
35 The Wnt signalling pathway. J Cell Sci 2000 1.00
36 Distribution of E-cadherin and Ep-CAM in the human lung during development and after injury. Histochem Cell Biol 1995 0.99
37 Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem 1995 0.96
38 Antituberculous therapy and acute liver failure. Lancet 1995 0.95
39 Adherens junction proteins in tumour progression. Cancer Surv 1995 0.94
40 Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis. Mol Carcinog 1997 0.93
41 Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol 1991 0.90
42 E-cadherin as an invasion suppressor. Ciba Found Symp 1995 0.90
43 Kikuchi disease (histiocytic necrotizing lymphadenitis) in association with HTLV1. Br J Dermatol 1997 0.89
44 Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients. Oncogene 2009 0.84
45 Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases. Br J Haematol 1992 0.82
46 [Smoking habits of employees and patients in the psychiatric department of a general hospital]. Gesundheitswesen 2004 0.81
47 Response of aplastic anaemia and scleroderma to cyclosporin. Br J Haematol 1993 0.79
48 Expression of E-cadherin/catenin complexes in breast cancer. Int J Oncol 1997 0.78
49 [Personal contextual factors of the ICF draft from the Working Group "ICF" of Specialty Group II of the Geman Society for Social Medicine and Prevention]. Gesundheitswesen 2010 0.78
50 [Intensified rehabilitation aftercare (IRENA): utilization alongside work and changes in work-related parameters]. Rehabilitation (Stuttg) 2011 0.78
51 Cultured microvascular endothelial cells (MVEC) differ in cytoskeleton, expression of cadherins and fibronectin matrix. A study under the influence of interferon-gamma. J Cell Sci 1993 0.78
52 United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma. Int J Lab Hematol 2008 0.77
53 [Assessment of generic and disease-specific health-related quality of life instruments in peripheral arterial disease]. Vasa 2008 0.77
54 [Adherence and cognitive performance in schizophrenia]. Fortschr Neurol Psychiatr 2010 0.76
55 [Participant structure of medical rehabilitation measures in Germany]. Rehabilitation (Stuttg) 2011 0.76
56 Intramucosal adenocarcinoma of the appendix. Endoscopy 2004 0.75
57 Fludarabine-induced tumour lysis in low-grade non-Hodgkin's lymphoma. Clin Lab Haematol 1997 0.75
58 Before empowerment: residents' memories of the role of the housemother in diaconal residential care settings in Germany 1945-1995. J Psychiatr Ment Health Nurs 2012 0.75
59 [Personal factors of the ICF]. Gesundheitswesen 2012 0.75
60 [Project "FrühStart"--family midwives in Saxony-Anhalt. Their networking with other health care and child welfare professionals and subjective view of the families]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2010 0.75
61 [Quality of life in the focus of quality audits in long-term care]. Gesundheitswesen 2012 0.75
62 [Company centredness in the rehabilitation system of the German Democratic Republic, GDR]. Rehabilitation (Stuttg) 2007 0.75
63 [The amount of professional nursing care in a gerontopsychiatric hospital--comparison of the system of the psychiatry personnel act and the long-term care insurance]. Gesundheitswesen 2009 0.75
64 Biomolecular markers of malignancy in human uveal melanoma: the role of the cadherin-catenin complex and gene expression profiling. Ophthalmologica 2003 0.75